Hosted by Burnet Institute, the annual Colloquium for the Centre for Research Excellence into Injecting Drug Use (CREIDU) will focus on ‘treatment as prevention’ – using treatment as a method of preventing the spread and harms of HIV and hepatitis C in people who inject drugs.
With an interactive format and exciting mix of speakers, the Colloquium is designed to draw together researchers, affected communities, policy makers and practitioners to discuss this exciting topic.
Among the key speakers are:
Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW, Australia.
Program Head and NHMRC Senior Research Fellow, Viral Hepatitis Epidemiology and Prevention Program, Kirby Institute, UNSW, Australia.
- Professor Frederick L. Altice
Professor of Medicine, Epidemiology and Public Health; Director of Clinical and Community Research;
Yale University School of Medicine and School of Public Health; Section of Infectious Diseases, AIDS Program and Division of Epidemiology of Microbial Diseases, USA.
Harm Reduction and HIV/AIDS Advisor, Médecins du Monde, France.
Executive Officer of the Australian Injecting & Illicit Drug Users League (AIVL), Australia.
- Professor Peter Vickerman
Professor in Infectious Disease Modelling at the University of Bristol and a member of LSHTM’s Social and Mathematical Epidemiology Group and the Centre for Research on Drugs and Health Behaviour (Faculty of Public Health and Policy), UK.
- Professor Margaret Hellard
Head, Centre for Population Health, Burnet Institute; Burnet Associate Director; Adjunct Professor, Monash University, DEPM, Australia.
- Professor Andrew Lloyd AM
Director Inflammation and Infection Research Centre, UNSW; Visiting Medical Officer, Justice Health, New South Wales.
Research Fellow, Australian Research Centre in Sex, Health and Society, Executive Member of the Coalition for the Eradication of Viral Hepatitis in Asia and the Pacific.
Medical Officer, Management of Substance Abuse, World Health Organization, Geneva, Switzerland.